{"mainPropery":{"diseaseId":652,"diseaseName":"Amebiasis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/652/amebiasis","synonyms":["Amoebic dysentery due to Entamoeba histolytica","Amoebiasis due to Entamoeba histolytica","Amebic dysentery","Intestinal amebiasis"],"synonyms-with-source":[{"name":"Amoebic dysentery due to Entamoeba histolytica"},{"name":"Amoebiasis due to Entamoeba histolytica"},{"name":"Amebic dysentery"},{"name":"Intestinal amebiasis"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":20,"diseaseTypeName":"Parasitic diseases"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=Entamoeba%5BTitle%5D%20AND%20histolytica%5BTitle%5D%20AND%20hasabstract%5Btext%5D%20AND%20English%5BLang%5D%20AND%20%28%22human%22%5BMeSH%20Terms%5D%20OR%20%22hominidae%22%5BMeSH%20Terms%5D%29%20AND%20%222002/09/03%2007.43%22%5BEDAT%5D%20%3A%20%222004/09/02%2007.43%22%5BEDAT%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Amebiasis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Amebiasis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Amebiasis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000298.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:9181' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":396,"genericName":"Tinidazole","tradeName":"TindamaxÂ®","tradeLink":"http://www.tindamax.com/","manufacturer":"Mission Pharmacal","sponsor":"Presutti Laboratories, Inc.","indication":"Treatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica in both adults and pediatric patients older than three years of age.  It is not indicated for the treatment of asymptomatic cyst passage.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Tindamax","medlinePlusLink":""}],"EncodedName":"Amebiasis"}